NO177186C - Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner - Google Patents

Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner

Info

Publication number
NO177186C
NO177186C NO913188A NO913188A NO177186C NO 177186 C NO177186 C NO 177186C NO 913188 A NO913188 A NO 913188A NO 913188 A NO913188 A NO 913188A NO 177186 C NO177186 C NO 177186C
Authority
NO
Norway
Prior art keywords
dihydropyridines
enantiomerically pure
polysubstituted
preparation
racemic
Prior art date
Application number
NO913188A
Other languages
English (en)
Norwegian (no)
Other versions
NO177186B (no
NO913188L (no
NO913188D0 (no
Inventor
Carmelo A Gandolfi
Marco Frigerio
Carlo Riva
Andrea Zaliani
Giorgio Long
Roberto Di Domenico
Original Assignee
Boehringer Mannheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Italia filed Critical Boehringer Mannheim Italia
Publication of NO913188L publication Critical patent/NO913188L/no
Publication of NO913188D0 publication Critical patent/NO913188D0/no
Publication of NO177186B publication Critical patent/NO177186B/no
Publication of NO177186C publication Critical patent/NO177186C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
NO913188A 1989-02-17 1991-08-15 Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner NO177186C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8919477A IT1230752B (it) 1989-02-17 1989-02-17 Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
PCT/EP1990/000243 WO1990009376A1 (en) 1989-02-17 1990-02-15 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines

Publications (4)

Publication Number Publication Date
NO913188L NO913188L (no) 1991-08-15
NO913188D0 NO913188D0 (no) 1991-08-15
NO177186B NO177186B (no) 1995-04-24
NO177186C true NO177186C (no) 1995-08-02

Family

ID=11158352

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913188A NO177186C (no) 1989-02-17 1991-08-15 Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner

Country Status (17)

Country Link
US (1) US5245039A (da)
EP (2) EP0458823B1 (da)
JP (1) JPH04505610A (da)
KR (1) KR0155557B1 (da)
AT (1) ATE95813T1 (da)
AU (1) AU630928B2 (da)
CA (1) CA2047741A1 (da)
DE (1) DE69003936T2 (da)
DK (1) DK0458823T3 (da)
ES (1) ES2060144T3 (da)
FI (1) FI95371C (da)
HU (1) HUT62270A (da)
IE (1) IE66498B1 (da)
IT (1) IT1230752B (da)
NO (1) NO177186C (da)
RU (1) RU2069658C1 (da)
WO (1) WO1990009376A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
CA2125149A1 (en) * 1991-12-02 1993-06-10 James W. Young Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
ES2055652B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2,3-diclorofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
ES2055653B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion del 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isopropil-5-(2-metoxi)etil.
ES2055654B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
ES2055655B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isobutil-5-metil.
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
FR2719585B1 (fr) * 1994-05-05 1996-08-02 Lafon Labor Procédé d'obtention de 1,4-dihydropyridines optiquement pures.
US5554621A (en) * 1995-06-07 1996-09-10 Bristol-Myers Squibb Company Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
ITMI20012434A1 (it) 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
WO1987000836A1 (en) * 1985-08-06 1987-02-12 Boehringer Biochemia Robin S.P.A. Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0296316B1 (de) * 1987-03-27 1993-09-01 Byk Gulden Lomberg Chemische Fabrik GmbH 1,4-Dihydropyridin-Enantiomere
AU1541188A (en) * 1987-03-27 1988-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh New optically active compounds

Also Published As

Publication number Publication date
EP0383320A1 (en) 1990-08-22
HUT62270A (en) 1993-04-28
NO177186B (no) 1995-04-24
FI913861A0 (fi) 1991-08-15
AU5090490A (en) 1990-09-05
ES2060144T3 (es) 1994-11-16
AU630928B2 (en) 1992-11-12
IE900584L (en) 1990-08-17
WO1990009376A1 (en) 1990-08-23
KR910700234A (ko) 1991-03-14
FI95371C (fi) 1996-01-25
DE69003936T2 (de) 1994-03-31
RU2069658C1 (ru) 1996-11-27
EP0458823B1 (en) 1993-10-13
NO913188L (no) 1991-08-15
JPH04505610A (ja) 1992-10-01
DK0458823T3 (da) 1994-02-21
IT8919477A0 (it) 1989-02-17
KR0155557B1 (ko) 1998-11-16
IE66498B1 (en) 1996-01-10
FI95371B (fi) 1995-10-13
ATE95813T1 (de) 1993-10-15
DE69003936D1 (de) 1993-11-18
US5245039A (en) 1993-09-14
EP0458823A1 (en) 1991-12-04
NO913188D0 (no) 1991-08-15
IT1230752B (it) 1991-10-29
CA2047741A1 (en) 1990-08-18

Similar Documents

Publication Publication Date Title
NO177186C (no) Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner
NO20083728L (no) Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid
DE3851070D1 (de) Verfahren zur Herstellung eines Oxid-Verbindungssupraleiterfadens.
IT7823679A0 (it) Processo enzimatico-microbiologico per la produzione di amminoacidi otticamente attivi a partire da idantoine e/o carbamil-derivati racemi.
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
JPS6486898A (en) Method for manufacturing ibuprofen
NO177500C (no) Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant
HUT45499A (en) Process for producing optically active 1,4-dihydropyridine derivatives
PT88078A (pt) Processo para a preparacao de acidos quinolonocarboxilicos
FR2614790B1 (fr) Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique
BR8806062A (pt) Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis
DE3382618D1 (de) Verfahren zur herstellung von(d)2-(6-methoxy-2-naphthyl)propionsaeure und pharmazeutisch verwendbaren salzen davon und neue zwischenprodukte.
HUT44126A (en) Herbicide composition containing pyridine-monocarboxylic acid derivative with sulfur-containing group at the 5th position as active component and process for producing the active component
PT87091A (pt) Process for preparing 3(5)-cyano-1h-pyrazole-4-carboxylic acid esters
AT375940B (de) Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze
AT358566B (de) Verfahren zur herstellung von neuen 1-naphthyl- essigsaeuren sowie deren estern, amiden und pharmazeutisch vertraeglichen salzen
DE69033833D1 (de) Verfahren zur Herstellung von Butantetracarbonsäure
ATA174887A (de) Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptansubstituierten prostaglandinether- und -thioetheranalogen und von deren stereoisomeren und pharmazeutisch annehmbaren salzen
ES2089327T3 (es) Procedimiento e intermediarios para la preparacion de un agente antivirico que contiene un grupo ciclobutilo.
DE3851942D1 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
AT358573B (de) Verfahren zur herstellung von (1,1-dithienyl- -(3-propen-(1)-yl-(3))-(1-phenyl-1-hydroxy- propyl-2))-amin und dessen saeureadditions- salzen und optisch aktiven isomeren
DE3564260D1 (en) 2-phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof
HUT46879A (en) Process for the racemization of optically active chrysanthemic acid and its ester